Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Lansoprazole suspension discontinued

According to the National electronic Library for Medicines, lansoprazole suspension (Zoton®) is to be discontinued.

The place in therapy for the suspension formulation has always been limited to patients who struggled to swallow a solid dosage form like a tablet or a capsule. The FasTab® formulation of lansoprazole would appear to be a cost-effective and suitable alternative. The Drug Tariff for August 2007 lists current prices as follows:

  • Lansoprazole 30mg orodispersible tablets (28) - £11.00
  • Lansoprazole 30mg gastro-resistant granules sachets (8) - £33.97

Action: Clinicians should be aware of this product discontinuation and ensure prescriptions are altered to a suitable alternative before supply issues arise.

Share 'Lansoprazole suspension discontinued' on Email Share 'Lansoprazole suspension discontinued' on Delicious Share 'Lansoprazole suspension discontinued' on Digg Share 'Lansoprazole suspension discontinued' on Facebook Share 'Lansoprazole suspension discontinued' on Google+ Share 'Lansoprazole suspension discontinued' on reddit Share 'Lansoprazole suspension discontinued' on StumbleUpon Share 'Lansoprazole suspension discontinued' on Twitter

atomic-wealth

No Comments to “Lansoprazole suspension discontinued”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,781 spam comments.

atomic-wealth
fond-illness
summer